Diabetes and Obesity

Body mass index (BMI) has a most common relationship to diabetes and insulin resistance. In obesity patents having an amount of no esterified fatty acids, cytokines, glycerol, pro-inflammatory markers, hormones, and other substances that are involved in the development of insulin resistance, is increased. The pathogenesis in the development of diabetes is depending on the fact that the β-islet cells of the pancreas are impaired, causing a lack of control of blood glucose. The development of diabetes becomes additional inevitable if the failure of β-islet cells of the pancreas is accompanied by insulin resistance. Body mass and weight gain and are central to the formation and rising incidence of type 1 and type2 diabetes.

  • Obesity and type 1 diabetes
  • Obesity and type 2 diabetes
  • Obesity and insulin resistance
  • Diabetes mellitus and obesity

Related Conference of Diabetes and Obesity

February 27-28, 2019

Asia Pacific Diabetes and Endocrinology Congress

Tokyo, Japan

April 17-18, 2019

21st Asia Pacific Diabetes Conference

Osaka,Japan
May 17-18, 2019

2nd Global Experts Meeting on Diabetes, Hypertension & Metabolic Syndrome

Holiday Inn Singapore Atrium | Singapore
May 30-31, 2019

2nd Global Meeting on Diabetes and Endocrinology

Istanbul, Turkey
June 27-28, 2019 |

18th Global Conference on Diabetes & Nursing Care

Amsterdam, Netherlands
July 17-18, 2019

28th European Diabetes Congress

| Edinburgh, Scotland
July 24-25, 2019

29th World Diabetes & Heart Congress

Melbourne, Australia
July 29-30, 2019

12th International Conference on Diabetes & Metabolism

Chicago | Illinois| USA
September 19-20, 2019

15th World Congress on Endocrinology & Diabetes

| Prague, Czech Republic
Oct 03-04, 2019

Euro Diabetes Congress & Expo

| Paris, France

Diabetes and Obesity Conference Speakers

Recommended Sessions

Related Journals

Are you interested in